| Abbreviation | Meaning |
| 17HDHA | (±)17-hydroxy-4Z,7Z,10Z,13Z,15E,19Z-docosahexaenoic acid |
| 4HDA | (±)4-hydroxy-5E,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid |
| 7HDHA | (±)7-hydroxy-4Z,8E,10Z,13Z,16Z,19Z-docosahexaenoic acid |
| AIS | acute ischemic stroke |
| AngII | angiotensin II |
| APP | beta-amyloid precursor protein |
| AQP4 | aquaporin-4 |
| Arg1 | arginase-1 |
| BBB | blood-brain barrier |
| CD | Crohn’s disease |
| CHO | Chinese hamster ovary cells |
| CI/R | cerebral ischemia/reperfusion |
| CNS | central nervous system |
| COVID-19 | coronavirus diseases 2019 |
| CXCL1 | chemokine ligand 1 |
| DAMPs | damage-associated molecular patterns |
| DM | diabetes mellitus |
| DMD | Duchenne muscular dystrophy |
| DMP1 | dentin matrix acidic phosphoprotein 1 |
| DRG | dorsal root ganglion |
| ECM | extracellular matrix |
| ECS | endocannabinoid system |
| ECs | endothelial cells |
| EVT | extravillous trophoblast |
| FAAH | fatty acid amide hydrolase |
| FDA | food and drug administration |
| FDA | Food and Drug Administration |
| GAFP | glial fibrillary acidic protein |
| GDG | Guideline Development Group |
| GM-CSF | granulocyte macrophage colony stimulating factor |
| GPR18 | G-protein coupled receptor 18 |
| HEK293 | human embryonic kidney 293 cells |
| HLI | hind limb ischemia |
| HTR-8 | normal human immortalised placental trophoblasts |
| HUASMC | human umbilical artery smooth muscle cells |
| IBD | inflammatory bowel diseases |
| IBS | irritable bowel syndrome |
| ICV | intracerebroventricular |
| IL-1β | interleukin-1β |
| IL-6 | interleukin-6 |
| IL-8 | interleukin-8 |
| IN | intranasal |
| IT | intrathecal |
| IV | intravenously |
| LPS | lipopolysaccharide |
| LTB4 | leukotriene B4 |
| LXA4 | lipoxin A4 |
| M1 | pro-inflammatory phenotype |
| M2 | anti-inflammatory phenotype |
| MAPK | mitogen-activated protein kinase |
| MBP | myelin basic protein |
| MCAO/R | middle cerebral artery occlusion and reperfusion |
| MMP-9 | metalloproteinase-9 |
| MPO | myeloperoxidase |
| NAGly | N-arachidonoylglycine |
| NF-κB | nuclear factor kappa B |
| PGJ2 | prostaglandin J2 |
| ROMO1 | reactive oxygen species modulator 1 |
| RvD2 | resolvin D2 (7S,16R,17S-trihydroxy-4Z,8E,10Z,12E,14E,19Z-docosahexaenoic acid) |
| SAH | subarachnoid hemorrhage |
| SCI | spinal cord injury |
| SNpc | substantia nigra pars compacta |
| SPMs | specialised pro-resolving mediators |
| TH | tyrosine hydroxylase |
| TNBS | 2,4,6-trinitrobenzenesulfonic acid |
| TNF-α | tumor necrosis factor alpha |
| TRP | Transient Receptor Potential |
| TRPV1 | transient potential receptor vanilloid 1 |
| UC | ulcerative colitis |
| VHS | visceral hypersensitivity |
| VMR | visceralmotor response |
| VSM | vascular smooth muscle |
| WHO | World Health Organisation |